Patents by Inventor Laila Berg

Laila Berg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9556440
    Abstract: The present invention concerns a method of producing a desired gene product in a recombinant gene expression system, said method comprising expressing said gene from a Pm promoter-based expression system using at least two mutant elements selected from: (i) a mutant Pm promoter; (ii) a mutant mRNA leader; and (iii) a mutant XyIS; wherein said mutant elements each comprise one or more mutations which enhance expression of said desired gene. Particularly combinations of a mutant Pm promoter and a mutant mRNA leader are concerned. Isolated nucleic acid molecules, vectors, host cells, libraries, expression systems, methods of enhancing expression, obtaining nucleic acid molecules and identifying combination mutants which enhance expression, artificially constructed operons and their uses are also encompassed.
    Type: Grant
    Filed: December 20, 2007
    Date of Patent: January 31, 2017
    Assignee: VECTRON BIOSOLUTIONS AS
    Inventors: Rahmi Lale, Laila Berg, Ingrid Bakke, Trond Erik Vee Aune, Svein Valla
  • Patent number: 9388421
    Abstract: The present invention concerns a method of producing a desired heterologous gene product wherein said heterologous gene product is expressed from a strong promoter, said method comprising expressing said gene using a mutant mRNA leader which comprises one or more mutations which enhance transcription of the gene. The invention also provides a mutant Pm mRNA leader sequence, and a vector and a library comprising the leader sequence. Methods of obtaining an mRNA mutant leader and identifying an mRNA mutant leader are encompassed, along with a vector for selection or identification of an mRNA leader mutant and a use thereof for screening.
    Type: Grant
    Filed: August 3, 2007
    Date of Patent: July 12, 2016
    Assignee: VECTRON BIOSOLUTIONS AS
    Inventors: Svein Valla, Rahmi Lale, Laila Berg, Ingrid Bakke
  • Publication number: 20100248972
    Abstract: The present invention concerns a method of producing a desired heterologous gene product wherein said heterologous gene product is expressed from a strong promoter, said method comprising expressing said gene using a mutant mRNA leader which comprises one or more mutations which enhance transcription of the gene. The invention also provides a mutant Pm mRNA leader sequence, and a vector and a library comprising the leader sequence. Methods of obtaining an mRNA mutant leader and identifying an mRNA mutant leader are encompassed, along with a vector for selection or identification of an mRNA leader mutant and a use thereof for screening.
    Type: Application
    Filed: August 4, 2007
    Publication date: September 30, 2010
    Inventors: Svein Valla, Rahmi Lale, Laila Berg, Ingrid Bakke
  • Publication number: 20100048426
    Abstract: The present invention concerns a method of producing a desired gene product in a recombinant gene expression system, said method comprising expressing said gene from a Pm promoter-based expression system using at least two mutant elements selected from: (i) a mutant Pm promoter; (ii) a mutant mRNA leader; and (iii) a mutant XyIS; wherein said mutant elements each comprise one or more mutations which enhance expression of said desired gene. Particularly combinations of a mutant Pm promoter and a mutant mRNA leader are concerned. Isolated nucleic acid molecules, vectors, host cells, libraries, expression systems, methods of enhancing expression, obtaining nucleic acid molecules and identifying combination mutants which enhance expression, artificially constructed operons and their uses are also encompassed.
    Type: Application
    Filed: December 20, 2007
    Publication date: February 25, 2010
    Inventors: Rahmi Lale, Laila Berg, Ingrid Bakke, Trond Erik Vee Aune, Svein Valla